Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
03/2004
03/04/2004WO2003015759A3 Treatment of hyperproliferative conditions of body surfaces
03/04/2004WO2003000846A3 A novel g protein-coupled receptor, gave 3
03/04/2004WO2002096867A3 Inhibitors of protein kinase for the treatment of disease
03/04/2004WO2002092762A3 Cytokine polypeptides
03/04/2004WO2002036158A8 Suspension of an epi-hne protein, process of preparation thereof, dry powder aerosol derived therefrom, pharmaceutical compositions containing said suspension or aerosol, and their uses
03/04/2004US20040044213 Process for making substituted 8-arylquinolinium benzenesulfonate
03/04/2004US20040044212 (Dihydro) Isoquinoline derivatives as phosphodiesterase inhibitors
03/04/2004US20040044194 Aggrecanase molecules
03/04/2004US20040044061 Analgesics; side effect reduction
03/04/2004US20040044051 Cannabinoid receptor agonists
03/04/2004US20040044050 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents
03/04/2004US20040044038 Polymorphic form XVI of fexofenadine hydrochloride
03/04/2004US20040044036 Piperidine derivatives and drugs containing these derivatives as active ingredient
03/04/2004US20040044035 Antiallergens; rhinitis
03/04/2004US20040044027 Induce immunology response; central nervous system disorders;sleep disorders; gastrointestinal disorders
03/04/2004US20040044026 3-Substituted quinuclidines and their use as nicotinic agonists
03/04/2004US20040044021 Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
03/04/2004US20040044018 Methods and pharmaceutical compositions for treatment of central and peripheral nervous system disorders and compounds useful therefor
03/04/2004US20040044002 Kinase inhibitors; antiproliferative agents; antiinflammatory agents; autoimmune diseases; skin disorders; anticancer agents; antiproliferative agents
03/04/2004US20040043999 Phthalazine derivatives as phosphodiesterase 4-inhibitors
03/04/2004US20040043929 Novel proteins and nucleic acids encoding same
03/04/2004US20040043926 Comprises polypeptides for diagnosing, treating and preventing cardiomyopathy, atherosclerosis and cancer
03/04/2004US20040043375 Regulation of human serine-threonine protein kinase
03/04/2004US20040042973 Anhydrous mometasome furoate mixture with surfactant and propellant; pressurized vessel; controlling particle size distribution
03/04/2004DE10238045A1 2-Thio-substituierte Imidazolderivate und ihre Verwendung in der Pharmazie 2-thio-substituted imidazole derivatives and their use in the pharmaceutical
03/04/2004CA2501849A1 2-thio-substituted imidazole derivatives and their use in treating diseases associated with a disorder of the immune system
03/04/2004CA2496573A1 Agent for prevention and/or treatment of asthma
03/04/2004CA2495689A1 Pharmaceutical compositions
03/04/2004CA2495603A1 Benzonaphthyridines with pde 3/4 inhibiting activity
03/04/2004CA2495597A1 Novel phenanthridines
03/04/2004CA2494974A1 Il-7 drug substance, composition, preparation and uses
03/04/2004CA2494650A1 Pyridazinone-derivatives as pde4 inhibitors
03/04/2004CA2494643A1 Piperidine-n-oxide-derivatives
03/04/2004CA2494634A1 Piperidine-pyridazones and phthalazones as pde4 inhibitors
03/03/2004EP1394274A2 Methods of testing for bronchial asthma or chronic obstructive pulmonary disease
03/03/2004EP1394161A1 L−ASCORBIC ACID−2−O−MALEIC ACID−A−TOCOPHEROL DIESTER 1−PROPANOL ADDUCT AND PROCESS FOR PRODUCING THE SAME
03/03/2004EP1394152A1 2-iminoimidazole derivatives (1)
03/03/2004EP1394150A1 4-Phenylpyridine derivatives and their use as NK-1 receptor antagonists
03/03/2004EP1392852A2 Nucleic acid-associated proteins
03/03/2004EP1392844A2 Use of hmg fragments as anti-inflammatory agents
03/03/2004EP1392831A2 Moraxella(branhamella) catarrhalis antigens
03/03/2004EP1392823A2 Desaturase genes and uses thereof
03/03/2004EP1392729A2 Use of a peptide which activates guanylate-cyclase c for the treatment of respiratory airway problems via the airways, medicament, inhalation devices and method of diagnosis
03/03/2004EP1392694A1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine and the use thereof for the preparation of pyrrolo[2,3]pyrimidine derivatives as protein kinases inhibitors
03/03/2004EP1392688A1 Pyrazino[1',2':1,6]pyrido[3,4-b]indole1,4-dione derivatives
03/03/2004EP1392687A1 1,3,8-triazaspiro[4,5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders
03/03/2004EP1392677A2 Chiral broad-spectrum antibacterial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation and compositions
03/03/2004EP1392661A1 Diarylurea derivatives useful as anti-inflammatory agents
03/03/2004EP1392655A2 Potassium channel openers
03/03/2004EP1392651A1 Heterocyclic ureas, their preparation and their use as vanilloid receptor antagonists
03/03/2004EP1392648A1 Hydroxamic acids and acyl hydroxamines as naaladase inhibitors
03/03/2004EP1392642A2 Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
03/03/2004EP1392623A1 Production and use of a polar lipid-rich fraction containing omega-3 and/or omega-6 highly unsatruated fatty acids from microbes, genetically modified plant seeds and marine organisms
03/03/2004EP1392351A2 Chemokines as adjuvants of immune response
03/03/2004EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
03/03/2004EP1392317A2 Substituted 1-benzazepines and derivatives thereof
03/03/2004EP1392306A1 Substituted tetrahydroisoquinolines for use in the treatment of inflammatory diseases
03/03/2004EP1392300A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
03/03/2004EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
03/03/2004EP1392289A2 Caspase inhibitors and uses thereof
03/03/2004EP1392276A1 Potentiation of therapeutic effects of polyunsaturated fatty acids
03/03/2004EP1392274A1 Improved dosage form of n-acetyl cysteine
03/03/2004EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same
03/03/2004EP1284974B1 Triazolyl tropane derivatives as ccr5 modulators
03/03/2004EP1196440B1 Therapeutic peptides derived from subsequences of bpi
03/03/2004EP1109571B1 Methods of treating salt-dependent hypertension
03/03/2004EP1037655B1 use of novel ligands of the neuropeptide receptor hfgan72 and antagonists thereof in therapy
03/03/2004EP0998484B1 Method of identifying compounds having reduced systemic effects
03/03/2004EP0998460B1 Novel tetrazole derivatives
03/03/2004EP0866726B1 Pulmonary administration of dry powder alpha 1-antitrypsin
03/03/2004EP0865430B1 3-(4-subst.-piperidinyl-1)-1-(3,4-dichlorophenyl)propyl carbamates and ureas and derivatives as novel neurokinin antagonists
03/03/2004EP0738268B1 Trisubstituted phenyl derivatives, processes for their preparation and their use as phosphodiesterase (type iv) inhibitors
03/03/2004EP0733103B1 Generation of high titers of recombinant aav vectors
03/03/2004EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide
03/03/2004EP0613375B1 Pharmaceutical lysine-containing polypeptide compositions and the use thereof
03/03/2004CN1479749A Polysaccharide compound having immune stimulating activity
03/03/2004CN1479739A Heterocyclic ether substituted imidazoquinolie compounds
03/03/2004CN1479738A Thioether subsituted imidazoquinoline compound
03/03/2004CN1479715A Amide for inhibition of IL-8-induced chemiotaxis of neutrophil leucocytes
03/03/2004CN1479625A Herbal pharmaceutical compositions for treating immun logical disorders
03/03/2004CN1478783A Inositol polyphosphate ester derivative and its using method
03/03/2004CN1478550A Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method
03/03/2004CN1478545A Use of compound interferon in the treating of SARS disease
03/03/2004CN1478522A Chinese medicine for treating chronic nasitis and its production method
03/03/2004CN1478520A Heat-clearing and detoxic medicine and its preparation method
03/03/2004CN1478494A Oral liquid for treating cough and asthma
03/03/2004CN1478477A Pectoral
03/03/2004CN1478472A 细胞粘连抑制剂 Cell adhesion inhibitor
03/03/2004CN1140525C 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives
03/02/2004US6700013 O-bromophenylacetic acid derivative chemical intermediate; smooth muscle relaxants, antiinflammatory agents; respiratory system disorders
03/02/2004US6699903 Hydration of the anhydrous lithium salt with acetonitrile and water; phosphodiesterase inhibitors
03/02/2004US6699899 Substituted acylhydroxamic acids and method of reducing TNFα levels
03/02/2004US6699893 Glucocorticoid receptor modulators
03/02/2004US6699888 Antiinflammatory
03/02/2004US6699877 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
03/02/2004US6699867 4-(4-Methyl-piperazin-1-ylmethyl)-4,5-dihydrothiazol-2-ylamine
03/02/2004US6699865 Protein kinase inhibitors, for treating cancer inflammatory disorders, restenosis, and cardiovascular disease.
03/02/2004US6699846 Such as ischemia and reperfusion injury, using specified glycolipids structurally related to monophosphoryl lipid a but with reduced proinflammatory and pyrogenic activity
03/02/2004US6699840 Controlled- or delayed-release forms of topiramate
03/02/2004US6699466 IL-16 antagonist peptides and DNA encoding the peptides